semaglutide black box warning (Ozempic) carries FDA warnings for thyroid C-cell tumors based on rodent studies, with emerging human data showing higher thyroid cancer risk in early users. Over 2,900 lawsuits allege inadequate warnings for Semaglutide and Autoimmune Disease: Safety

Platelet-rich plasma treatment for large joint osteoarthritis: Retrospective study highlighting a possible treatment protocol with long-lasting stimulation of the joint with an adequate dose of platelets

Research published in Cell Discovery examined the structural basis for retatrutide activating all three receptors, confirming that its molecular design allows potent simultaneous activation rather than weak partial agonism at any single receptor

PMID: 35011559

& Giroux, I

Liraglutide persistence data further illustrate this challenge real-world studies indicate an average treatment duration of only 6.3 months, suggesting most patients discontinue before reaching the conventional 6-month assessment point typically used in clinical guidelines

Gillespie AH, Doctor A